Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
greater 32 39 32 39 O
than 40 44 40 44 O
or 45 47 45 47 O
equal 48 53 48 53 O
to 54 56 54 56 O
1,500 57 62 57 62 B-lower_bound
/ 62 63 62 63 I-lower_bound
mcl 63 66 63 66 I-lower_bound
, 66 67 66 67 O
equivalent 68 78 68 78 O
to 79 81 79 81 O
Common 82 88 82 88 O
Toxicity 89 97 89 97 O
Criteria 98 106 98 106 O
( 107 108 107 108 O
CTCAE 108 113 108 113 O
v4.0 114 118 114 118 O
) 118 119 118 119 O
Grade 120 125 120 125 O
1 126 127 126 127 O
. 127 128 127 128 O
Platelets 129 138 129 138 B-clinical_variable
greater 139 146 139 146 O
than 147 151 147 151 O
or 152 154 152 154 O
equal 155 160 155 160 O
to 161 163 161 163 O
100,000 164 171 164 171 B-lower_bound
/ 171 172 171 172 I-lower_bound
mcl 172 175 172 175 I-lower_bound
( 176 177 176 177 O
CTCAE 177 182 177 182 O
v4.0 183 187 183 187 O
Grade 188 193 188 193 O
0 194 195 194 195 O
- 195 196 195 196 O
1 196 197 196 197 O
) 197 198 197 198 O
. 198 199 198 199 O
Hemoglobin 200 210 200 210 B-clinical_variable
( 211 212 211 212 I-clinical_variable
Hgb 212 215 212 215 I-clinical_variable
) 215 216 215 216 I-clinical_variable
greater 217 224 217 224 O
than 225 229 225 229 O
or 230 232 230 232 O
equal 233 238 233 238 O
to 239 241 239 241 O
9.0g 242 246 242 246 B-lower_bound
/ 246 247 246 247 I-lower_bound
dl 247 249 247 249 I-lower_bound
( 250 251 250 251 O
CTCAE 251 256 251 256 O
v4.0 257 261 257 261 O
Grade 262 267 262 267 O
2 268 269 268 269 O
) 269 270 269 270 O

Bilirubin 0 9 271 280 B-clinical_variable
less 10 14 281 285 O
than 15 19 286 290 O
or 20 22 291 293 O
equal 23 28 294 299 O
to 29 31 300 302 O
1.5 32 35 303 306 B-upper_bound
x 36 37 307 308 I-upper_bound
ULN 38 41 309 312 I-upper_bound
( 42 43 313 314 O
CTCAE 43 48 314 319 O
v4.0 49 53 320 324 O
Grade 54 59 325 330 O
1 60 61 331 332 O
) 61 62 332 333 O
. 62 63 333 334 O
Serum 64 69 335 340 B-clinical_variable
glutamate 70 79 341 350 I-clinical_variable
oxaloacetate 80 92 351 363 I-clinical_variable
transaminase 93 105 364 376 I-clinical_variable
( 106 107 377 378 I-clinical_variable
SGOT 107 111 378 382 I-clinical_variable
) 111 112 382 383 I-clinical_variable
and 113 116 384 387 O
alkaline 117 125 388 396 B-clinical_variable
phosphatase 126 137 397 408 I-clinical_variable
â‰¤ 138 139 409 410 O
2.5 140 143 411 414 B-upper_bound
x 144 145 415 416 I-upper_bound
ULN 146 149 417 420 I-upper_bound
( 150 151 421 422 O
CTCAE 151 156 422 427 O
v4.0 157 161 428 432 O
Grade 162 167 433 438 O
1 168 169 439 440 O
) 169 170 440 441 O

Creatinine 0 10 442 452 B-clinical_variable
less 11 15 453 457 O
than 16 20 458 462 O
or 21 23 463 465 O
equal 24 29 466 471 O
to 30 32 472 474 O
1.5 33 36 475 478 B-upper_bound
x 37 38 479 480 I-upper_bound
institutional 39 52 481 494 I-upper_bound
upper 53 58 495 500 I-upper_bound
limit 59 64 501 506 I-upper_bound
normal 65 71 507 513 I-upper_bound
( 72 73 514 515 I-upper_bound
ULN 73 76 515 518 I-upper_bound
) 76 77 518 519 I-upper_bound
, 77 78 519 520 O
CTCAE 79 84 521 526 O
v4.0 85 89 527 531 O
Grade 90 95 532 537 O
1 96 97 538 539 O

Flaxseed 0 8 540 548 B-treatment
supplementation 9 24 549 564 O
may 25 28 565 568 O
be 29 31 569 571 O
contraindicated 32 47 572 587 O
in 48 50 588 590 O
patients 51 59 591 599 O
with 60 64 600 604 O
acute 65 70 605 610 B-chronic_disease
abdomen 71 78 611 618 I-chronic_disease
, 78 79 618 619 O
esophageal 80 90 620 630 B-chronic_disease
stricture 91 100 631 640 I-chronic_disease
or 101 103 641 643 I-chronic_disease
perforation 104 115 644 655 I-chronic_disease
, 115 116 655 656 O
dysphagia 117 126 657 666 B-chronic_disease
, 126 127 666 667 O
GI 128 130 668 670 B-chronic_disease
obstruction 131 142 671 682 I-chronic_disease
or 143 145 683 685 O
ileus 146 151 686 691 B-chronic_disease
, 151 152 691 692 O
acute 153 158 693 698 B-chronic_disease
intestinal 159 169 699 709 I-chronic_disease
inflammation 170 182 710 722 I-chronic_disease
or 183 185 723 725 O
unexplained 186 197 726 737 O
abdominal 198 207 738 747 O
pain 208 212 748 752 O
. 212 213 752 753 O
Patients 214 222 754 762 O
with 223 227 763 767 O
any 228 231 768 771 O
of 232 234 772 774 O
these 235 240 775 780 O
conditions 241 251 781 791 O
will 252 256 792 796 O
be 257 259 797 799 O
excluded 260 268 800 808 O
from 269 273 809 813 O
this 274 278 814 818 O
trial 279 284 819 824 O
as 285 287 825 827 O
the 288 291 828 831 O
high 292 296 832 836 O
fiber 297 302 837 842 O
content 303 310 843 850 O
of 311 313 851 853 O
flaxseed 314 322 854 862 O
may 323 326 863 866 O
make 327 331 867 871 O
these 332 337 872 877 O
conditions 338 348 878 888 O
worse 349 354 889 894 O

Patient 0 7 895 902 O
has 8 11 903 906 O
received 12 20 907 915 O
other 21 26 916 921 O
investigational 27 42 922 937 O
drugs 43 48 938 943 O
within 49 55 944 950 O
28 56 58 951 953 B-upper_bound
days 59 63 954 958 I-upper_bound
before 64 70 959 965 O
enrollment 71 81 966 976 O

Patients 0 8 977 985 O
concurrently 9 21 986 998 O
using 22 27 999 1004 O
anticoagulants 28 42 1005 1019 B-treatment
/ 42 43 1019 1020 O
antiplatelets 43 56 1020 1033 B-treatment
on 57 59 1034 1036 O
a 60 61 1037 1038 O
DAILY 62 67 1039 1044 O
BASIS 68 73 1045 1050 O
, 73 74 1050 1051 O
including 75 84 1052 1061 O
aspirin 85 92 1062 1069 B-treatment
, 92 93 1069 1070 O
Clopidogrel 94 105 1071 1082 B-treatment
( 106 107 1083 1084 I-treatment
Plavix 107 113 1084 1090 I-treatment
) 113 114 1090 1091 I-treatment
, 114 115 1091 1092 O
Ticlopidine 116 127 1093 1104 B-treatment
( 128 129 1105 1106 I-treatment
Ticlid 129 135 1106 1112 I-treatment
) 135 136 1112 1113 I-treatment
, 136 137 1113 1114 O
and 138 141 1115 1118 O
Coumadin 142 150 1119 1127 B-treatment

Patients 0 8 1128 1136 O
unable 9 15 1137 1143 O
to 16 18 1144 1146 O
tolerate 19 27 1147 1155 O
and/or 28 34 1156 1162 O
allergies 35 44 1163 1172 O
to 45 47 1173 1175 O
flaxseed 48 56 1176 1184 B-allergy_name
or 57 59 1185 1187 I-allergy_name
flaxseed 60 68 1188 1196 I-allergy_name
preparations 69 81 1197 1209 I-allergy_name

Patients 0 8 1210 1218 O
who 9 12 1219 1222 O
are 13 16 1223 1226 O
pregnant 17 25 1227 1235 B-pregnancy

Patients 0 8 1236 1244 O
who 9 12 1245 1248 O
have 13 17 1249 1253 O
received 18 26 1254 1262 O
prior 27 32 1263 1268 O
radiotherapy 33 45 1269 1281 B-treatment
or 46 48 1282 1284 O
chemotherapy 49 61 1285 1297 B-treatment
for 62 65 1298 1301 O
another 66 73 1302 1309 O
malignancy 74 84 1310 1320 B-cancer

Patients 0 8 1321 1329 O
with 9 13 1330 1334 O
Gynecologic 14 25 1335 1346 B-clinical_variable
Oncology 26 34 1347 1355 I-clinical_variable
Group 35 40 1356 1361 I-clinical_variable
( 41 42 1362 1363 I-clinical_variable
GOG 42 45 1363 1366 I-clinical_variable
) 45 46 1366 1367 I-clinical_variable
performance 47 58 1368 1379 I-clinical_variable
status 59 65 1380 1386 I-clinical_variable
> 66 67 1387 1388 O
2 68 69 1389 1390 B-lower_bound

Patients 0 8 1391 1399 O
with 9 13 1400 1404 O
a 14 15 1405 1406 O
diagnosis 16 25 1407 1416 O
of 26 28 1417 1419 O
OC 29 31 1420 1422 B-cancer
including 32 41 1423 1432 O
epithelial 42 52 1433 1443 B-cancer
ovarian 53 60 1444 1451 I-cancer
carcinoma 61 70 1452 1461 I-cancer
, 70 71 1461 1462 O
primary 72 79 1463 1470 B-cancer
peritoneal 80 90 1471 1481 I-cancer
cancer 91 97 1482 1488 I-cancer
or 98 100 1489 1491 O
fallopian 101 110 1492 1501 B-cancer
tube 111 115 1502 1506 I-cancer
cancer 116 122 1507 1513 I-cancer
who 123 126 1514 1517 O
are 127 130 1518 1521 O
currently 131 140 1522 1531 O
in 141 143 1532 1534 O
clinical 144 152 1535 1543 B-treatment
remission 153 162 1544 1553 I-treatment
as 163 165 1554 1556 O
determined 166 176 1557 1567 O
by 177 179 1568 1570 O
the 180 183 1571 1574 O
PI 184 186 1575 1577 O
or 187 189 1578 1580 O
co 190 192 1581 1583 O
- 192 193 1583 1584 O
I 193 194 1584 1585 O
and 195 198 1586 1589 O
are 199 202 1590 1593 O
within 203 209 1594 1600 O
4 210 211 1601 1602 B-upper_bound
months 212 218 1603 1609 I-upper_bound
of 219 221 1610 1612 O
completion 222 232 1613 1623 O
of 233 235 1624 1626 O
cancer 236 242 1627 1633 B-treatment
treatment 243 252 1634 1643 I-treatment

Patients 0 8 1644 1652 O
with 9 13 1653 1657 O
a 14 15 1658 1659 O
diagnosis 16 25 1660 1669 O
of 26 28 1670 1672 O
/ 28 29 1672 1673 O
problems 29 37 1673 1681 O
with 38 42 1682 1686 O
von 43 46 1687 1690 B-chronic_disease
Willebrand 47 57 1691 1701 I-chronic_disease
's 57 59 1701 1703 I-chronic_disease
disease 60 67 1704 1711 I-chronic_disease
or 68 70 1712 1714 O
other 71 76 1715 1720 O
bleeding 77 85 1721 1729 B-chronic_disease
disorders 86 95 1730 1739 I-chronic_disease
( 96 97 1740 1741 O
as 97 99 1741 1743 O
flaxseed 100 108 1744 1752 O
may 109 112 1753 1756 O
slow 113 117 1757 1761 O
blood 118 123 1762 1767 O
clotting 124 132 1768 1776 O
; 132 133 1776 1777 O
the 134 137 1778 1781 O
risk 138 142 1782 1786 O
of 143 145 1787 1789 O
bruising 146 154 1790 1798 O
or 155 157 1799 1801 O
bleeding 158 166 1802 1810 O
in 167 169 1811 1813 O
people 170 176 1814 1820 O
on 177 179 1821 1823 O
anticoagulants 180 194 1824 1838 B-treatment
or 195 197 1839 1841 O
with 198 202 1842 1846 O
bleeding 203 211 1847 1855 O
disorders 212 221 1856 1865 O
may 222 225 1866 1869 O
be 226 228 1870 1872 O
a 229 230 1873 1874 O
concern 231 238 1875 1882 O
) 238 239 1882 1883 O

Patients 0 8 1884 1892 O
with 9 13 1893 1897 O
a 14 15 1898 1899 O
history 16 23 1900 1907 O
of 24 26 1908 1910 O
inflammatory 27 39 1911 1923 B-chronic_disease
bowel 40 45 1924 1929 I-chronic_disease
disease 46 53 1930 1937 I-chronic_disease
, 53 54 1937 1938 O
problems 55 63 1939 1947 O
with 64 68 1948 1952 O
chronic 69 76 1953 1960 B-chronic_disease
diarrhea 77 85 1961 1969 I-chronic_disease
or 86 88 1970 1972 O
history 89 96 1973 1980 O
of 97 99 1981 1983 O
bowel 100 105 1984 1989 B-chronic_disease
obstruction 106 117 1990 2001 I-chronic_disease

Patients 0 8 2002 2010 O
with 9 13 2011 2015 O
a 14 15 2016 2017 O
history 16 23 2018 2025 O
of 24 26 2026 2028 O
uncontrolled 27 39 2029 2041 B-chronic_disease
diabetes 40 48 2042 2050 I-chronic_disease
( 49 50 2051 2052 O
as 50 52 2052 2054 O
flaxseed 53 61 2055 2063 O
can 62 65 2064 2067 O
lower 66 71 2068 2073 O
blood 72 77 2074 2079 O
glucose 78 85 2080 2087 O
levels 86 92 2088 2094 O
and 93 96 2095 2098 O
might 97 102 2099 2104 O
have 103 107 2105 2109 O
additive 108 116 2110 2118 O
effects 117 124 2119 2126 O
when 125 129 2127 2131 O
used 130 134 2132 2136 O
with 135 139 2137 2141 O
anti 140 144 2142 2146 B-treatment
- 144 145 2146 2147 I-treatment
diabetic 145 153 2147 2155 I-treatment
drugs 154 159 2156 2161 I-treatment
) 159 160 2161 2162 O

Patients 0 8 2163 2171 O
with 9 13 2172 2176 O
concurrent 14 24 2177 2187 O
uncontrolled 25 37 2188 2200 B-chronic_disease
illness 38 45 2201 2208 I-chronic_disease

Patients 0 8 2209 2217 O
with 9 13 2218 2222 O
ovarian 14 21 2223 2230 B-cancer
cancer 22 28 2231 2237 I-cancer
of 29 31 2238 2240 O
low 32 35 2241 2244 O
malignant 36 45 2245 2254 O
potential 46 55 2255 2264 O
( 56 57 2265 2266 O
borderline 57 67 2266 2276 B-cancer
cancers 68 75 2277 2284 I-cancer
) 75 76 2284 2285 O

Patients 0 8 2286 2294 O
with 9 13 2295 2299 O
serious 14 21 2300 2307 O
medical 22 29 2308 2315 O
or 30 32 2316 2318 O
psychiatric 33 44 2319 2330 B-chronic_disease
illness 45 52 2331 2338 I-chronic_disease

Renal 0 5 2339 2344 B-chronic_disease
function 6 14 2345 2353 I-chronic_disease

Women 0 5 2354 2359 B-gender
of 6 8 2360 2362 O
childbearing 9 21 2363 2375 O
potential 22 31 2376 2385 O
must 32 36 2386 2390 O
have 37 41 2391 2395 O
a 42 43 2396 2397 O
negative 44 52 2398 2406 B-pregnancy
pregnancy 53 62 2407 2416 I-pregnancy
test 63 67 2417 2421 O

patients 0 8 2422 2430 O
of 9 11 2431 2433 O
any 12 15 2434 2437 O
stage 16 21 2438 2443 O
who 22 25 2444 2447 O
are 26 29 2448 2451 O
in 30 32 2452 2454 O
remission 33 42 2455 2464 O
who 43 46 2465 2468 O
have 47 51 2469 2473 O
undergone 52 61 2474 2483 O
surgical 62 70 2484 2492 B-treatment
debulking 71 80 2493 2502 I-treatment
and 81 84 2503 2506 O
adjuvant 85 93 2507 2515 B-treatment
chemotherapy 94 106 2516 2528 I-treatment

